Asuragen Scientific Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows
John N. Milligan, Laura Blasco-Pérez, Mar Costa-Roger, Marta Codina-Solà, and Eduardo F. Tizzano
Dried Blood Spot Testing with AmplideX® SMA Plus* Kit Resolves SMN1 and SMN2 Exon 7 Copy Numbers and More
Sarah Edelmon, Walairat Laosinchai-Wolf, Laura Blasco-Pérez, Mar Costa-Roger, Ivon Cuscó, Gary J Latham, Eduardo F Tizzano, and John N Milligan
A Genetic Enrichment Strategy for Delay of Onset of Alzheimer’s Disease Clinical Trials
MW Lutz, DK Burns, R Alexander, M Culp, D Yarnall, S Haneline, C Chiang, E Lai, C Metz, S Sundseth, T Guennel, S Marshall, BF Andruss, GJ Latham, B Hall, SN Statt, T Swanson, E Ratti and AM Saunders
Democratizing Carrier Screening: A 35-Gene Panel of Routine and Challenging Targets Resolved Using a Single Workflow
James Hernandez, Bradley Hall, Jon Kemppainen, Julie Thibert, Cody Edwards, Liangjing Chen, Ryan Routsong, Chris Fraher, Theodore Markulin, Melissa Church, Jacob Wisotsky, Jonathan Turner, Justin Janovsky, Stela Filipovic-Sadic, Gary J Latham, Brian C Haynes and Sarah Statt
Enabling Single-Platform Testing and Carrier Screening of the FMR1, SMN1/2, and CFTR Gene Trio
Sarah Edelmon, Walairat Laosinchai-Wolf, Gary J Latham, and John N Milligan
QuantideX qPCR BCR-ABL IS Kit and ipsogen BCR-ABL1 Mbcr IS-MMR Kit Yield Highly Correlated Results
Adrian Lara, Ion Beldorth, Keri Jefferson, Justin T Brown
Refining reproductive risk for FMR1 premutation carriers in the general obstetric population
Owens KM, et al. Am J Med Genet A. 2022 Feb. doi: 10.1002/ajmg.a.62666
Back To